http://orcid.org/0000-0003-1949-4007
References
- Acar, Y. A., Kalkan, M., Cetin, R., Cevik, E., & Cinar, O. (2014). Acute psychotic symptoms due to benzydamine hydrochloride abuse with alcohol. Case Reports in Psychiatry, 290365. doi:10.1155/2014/290365
- Anand, J. S., Glebocka, M. L., & Korolkiewicz, R. P. (2007). Recreational abuse with benzydamine hydrochloride (tantum rosa). Clinical Toxicology, 45, 198–199. doi:10.1080/15563650600981210
- Avvisati, R., Meringolo, M., Stendardo, E., Malavasi, E., Marinelli, S., & Badiani, A. (2018). Intravenous self‐administration of benzydamine, a non‐steroidal anti‐inflammatory drug with a central cannabinoidergic mechanism of action. Addiction Biology, 23, 610–619. doi:10.1111/adb.12516
- Balaban, O., Atagun, M., Yilmaz, H., Yazar, M., & Alpkan, M. (2013). Benzydamine abuse as a hallucinogen: A case report. Bulletin of Clinical Psychopharmacology, 23, 276. doi:10.5455/bcp.20111212083751
- Baldock, G. A., Brodie, R. R., Chasseaud, L. F., Taylor, T., Walmsley, L. M., & Catanese, B. (1991). Pharmacokinetics of benzydamine after intravenous, oral, and topical doses to human subjects. Biopharmaceutics & Drug Disposition, 12,481–492. doi:10.1002/bdd.2510120702
- Ballesteros, S., Ram´On, M. F., & Mart´ınez-Arrieta, R. (2009). Ingestions of benzydamine-containing vaginal preparations. Clinical Toxicology, 47, 145–149. doi:10.3109/15563650903333820
- Can, B., Oz, I., Ozer, H., & Simsek, T. (2016). Hallucinations after ingesting a high dose of benzydamine hydrochloride. Clinical Psychopharmacology and Neuroscience, 14, 407–408. doi:10.9758/cpn.2016.14.4.407
- Doğan, M., Yılmaz, C., Caksen, H., & Guven, A. S. (2006). A case of benzydamine HCL intoxication. Eastern Journal of Medicine, 11, 26–28.
- Doksat, M. K. (2009). Reversible worsening of psychosis due to benzydamine in a schizoaffective young girl who is already under treatment with antipsychotics. Bulletin of Clinical Psychopharmacology, 19, 279–284.
- Egan, C. T., Herrick-Davis, K., Miller, K., Glennon, R. A., & Teitler, M. (1998). Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors. Psychopharmacology, 136, 409–414. doi:10.1007/s002130050585.
- Fanaki, N. H., & El-Nakeeb, M. A. (1992). Antimicrobial activity of benzydamine, a non-steroid anti-inflammatory agent. Journal of Chemotherapy, 4, 347–352. doi:10.1080/1120009X.1992.11739190
- Opaleye, E. S., Noto, A. R., Sanchez, Z. M., Moura, Y. G., Galduroz, J. C., & Carlini, E. A. (2009). Recreational use of benzydamine as a hallucinogen among street youth in Brazil. Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999), 31, 208–213. doi:10.1590/S1516-44462009000300005
- Pınar, Ç. A., Güliz, Ö., Çekiç, M., & Doğan, O. (2014). Benzydamine abuse in a case with psychosis related to multiple substance abuse. Anatolian Journal of Psychiatry, 15, S4–S6. doi:10.5455/apd.43506
- Saldanha, V. B., Plein, F. A., & Jornada, L. K. (1993). Non-medical use of benzydamine: A case report. Jornal Brasileiro De Psiquiatria, 42, 503–505.
- Schifano, F., Corazza, O., Marchi, A., Di Melchiorre, G., Sferrazza, E., Enea, A., & Deluca, P. (2013). Psychonaut web mapping e rednet research projects. Analysis of online reports on the potential misuse of benzidamine. Rivista Di Psichiatria, 48, 182–186. doi:10.1708/1292.14286
- Zaprutko, T., Koligat, D., Michalak, M., Wieczorek, M., Józiak, M., Ratajczak, M., & Nowakowska, E. (2016). Misuse of OTC drugs in Poland. Health Policy (Amsterdam, Netherlands), 120, 875–881. doi:10.1016/j.healthpol.2016.06.008.